《Healthcare Reform in China.ppt》由会员分享，可在线阅读，更多相关《Healthcare Reform in China.ppt（7页珍藏版）》请在三一办公上搜索。
1、Healthcare Reform in China,Assessment of changes to pricing,regulation,and infrastructure,and opportunities for stakeholders,BI00050-012October 2011112 pages,13 figures,13 tablesStrategy,China,National insurance reformsNational reimbursement listsDrug price reformsHospital drug distribution reformsC
2、linic and hospital investmentsHealth IT reforms,Pharmaceutical companiesCROsPrivate health insurersHospitalsHealthcare IT providers,Chinas pharma market to reach$100bn by 2016,Chinas pharmaceutical market will grow at a CAGR of 17%to exceed$100bn in 2016,becoming the third largest market globallyPop
3、ulation is forecast to increase by 85m people between 2010 and 2020.85%of this will be accounted for by an increase in over 60s.Chinas ageing population will prompt growth in markets for cardiovascular diseases,dementia,and other age-linked conditions.,Ch.1 Chinas Changing Population Sec:Introductio
4、n;Change in therapeutic focus,Source:International Diabetes Federation;Yang et al,2010,Chinas middle class to increase by 80%from 2010 to 2015,Chinas population is becoming increasingly urbanized creating opportunities for multinational firms in areas such as clinical trialsBy 2016,China will have m
5、ore urban than rural citizens2nd and 3rd tier cities are key economic growth areas which should be part of multinationals marketing strategies,Ch 2.Chinas Changing Population Sec:The rise of the middle class and increase in spending power;Urbanization,Basic health insurance to be offered universally
6、 by 2020,The proportion of out-of-pocket healthcare expenditure on healthcare dropped from 60%in 2001 to 40%in 2008 due to the increasing coverage of social health insurance schemes.In 2009,the Chinese government announced RMB 850bn($124bn)of investment in healthcare reforms.Reforms aim to extend ba
7、sic healthcare coverage to 90%of the population by 2012 and universal coverage by 2020.95%of urban workers were covered by Basic Medical Insurance by the end of 2009;however students,the self-employed,and the elderly are not eligible.The Urban Resident Basic Medical Insurance program aims to cover u
8、rban residents regardless of employment status.Enrollment is on a voluntary basis by household.The National Reimbursement Drug List is a list of drugs which are wholly or substantially reimbursed when provided to those covered by state insurance programs.,Ch.2 Chinas healthcare system and the need f
9、or reform.Sec:Overview;History of Chinese healthcare;Organization of healthcare and the hospital system,National Drug Reiumbursement List offers deep market access,Whilst limiting margins,presence on the list drives sales volumes,and brand awareness The list of drugs reimbursed by the government is
10、periodically updatedAs reforms continue,and multinationals seek greater market penetration,more drugs will be added to the list in future,Ch.3.Healthcare reform in China.Sec:Pharmaceutical companies,Source:Business Insights,Chinese private health insurance market to grow at 22%per year,Private healt
11、h insurance will be among the fastest growing of the healthcare industries Although prices are lower,listing on the National Drug Reimbursement List offers large opportunities in sales volume and market accessClinical research in hospitals will receive greater funding under reforms,which will be a b
12、oost for CROs.Urbanization and insurance coverage extensions will also favor the industry.Healthcare IT companies also have large opportunities arising in the fields of clinical information systems,electronic health records,Ch.4 Implications of reforms for stakeholders.Sec:Introduction;Pharmaceutical companies;Hospitals;CROs,Source:McKinsey&Co.,Business Insights,Innovative Drug Discovery in Emerging Markets,BI00020-035,BI00022-059,BI00022-023,Opportunities in Emerging Pharma Markets,The OTC Pharmaceutical Market in Emerging Countries,
